R&D Grants Awarded to B-MoGen Biotechnologies, Inc.


08.08.18
Development of mitochondrial disease mouse models
B-MoGen Biotechnologies has been awarded a grant from the NIH for development of mitochondrial disease mouse models

08.06.18
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy
B-MoGen Biotechnologies has been awarded a grant from the NIH for Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy